XPONANCE LLC

Position in NKTR — Nektar Therapeutics

CIK 1637541 PHILADELPHIA, PA

Position in NKTR

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$235,538

+$227,249 QoQ

Shares Held

3,374

+315.0% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#178

of 239 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XPONANCE LLC holds $117,846,021 across 121 Biotechnology names. NKTR ranks #69 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,980	$22,839,645
2	REGN	Regeneron Pharmaceuticals, Inc.	18,063	$11,263,003
3	ALNY	Alnylam Pharmaceuticals, Inc.	30,242	$9,103,749
4	RVMD	Revolution Medicines, Inc.	40,460	$7,577,348
5	INSM	INSMED Inc	48,273	$5,146,867
6	INCY	Incyte Corp	29,027	$3,290,500
7	RPRX	Royalty Pharma plc	55,752	$3,126,014
8	MRNA	Moderna, Inc.	39,368	$2,756,941

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$235,538	3,374	-72.3%	Shares	Sole	2026-08-10
2025-03-31	$8,289	12,190	+2.5%	Shares	Sole	2025-05-01
2024-12-31	$11,056	11,889	+10.1%	Shares	Sole	2025-02-11
2024-09-30	$14,037	10,798	-5.7%	Shares	Sole	2024-11-12
2024-06-30	$14,202	11,454	+10.8%	Shares	Sole	2024-08-14
2023-03-31	$7,238	10,341	0.0%	Shares	Sole	2023-04-18
2022-12-31	$23,370	10,341	+1.7%	Shares	Sole	2023-01-24
2022-09-30	$32,547	10,171	-50.7%	Shares	Sole	2022-10-24
2021-09-30	$370,766	20,644	-3.2%	Shares	Sole	2021-11-05
2021-06-30	$365,919	21,324	+11.0%	Shares	Sole	2021-08-12
2021-03-31	$384,060	19,203	+2.1%	Shares	Sole	2021-05-10
2020-12-31	$319,719	18,807	-0.1%	Shares	Sole	2021-02-11
2020-09-30	$312,439	18,833	+17.2%	Shares	Sole	2020-10-26
2020-06-30	$372,111	16,067	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.